903 related articles for article (PubMed ID: 32905015)
21.
Lawal B; Tsai SK; Wu ATH; Huang HS
Arab J Chem; 2023 May; 16(5):104654. PubMed ID: 36777994
[TBL] [Abstract][Full Text] [Related]
22. Role of Structural and Non-Structural Proteins and Therapeutic Targets of SARS-CoV-2 for COVID-19.
Yadav R; Chaudhary JK; Jain N; Chaudhary PK; Khanra S; Dhamija P; Sharma A; Kumar A; Handu S
Cells; 2021 Apr; 10(4):. PubMed ID: 33917481
[TBL] [Abstract][Full Text] [Related]
23. SARS-CoV-2 infection and smoking: What is the association? A brief review.
Gupta I; Sohail MU; Elzawawi KE; Amarah AH; Vranic S; Al-Asmakh M; Al Moustafa AE
Comput Struct Biotechnol J; 2021; 19():1654-1660. PubMed ID: 33777332
[TBL] [Abstract][Full Text] [Related]
24. Recent progress and challenges in drug development against COVID-19 coronavirus (SARS-CoV-2) - an update on the status.
Abd El-Aziz TM; Stockand JD
Infect Genet Evol; 2020 Sep; 83():104327. PubMed ID: 32320825
[TBL] [Abstract][Full Text] [Related]
25. Current concepts in the development of therapeutics against human and animal coronavirus diseases by targeting NP.
Tseng YY; Liao GR; Lien A; Hsu WL
Comput Struct Biotechnol J; 2021; 19():1072-1080. PubMed ID: 33552444
[TBL] [Abstract][Full Text] [Related]
26. Update of the current knowledge on genetics, evolution, immunopathogenesis, and transmission for coronavirus disease 19 (COVID-19).
Tizaoui K; Zidi I; Lee KH; Ghayda RA; Hong SH; Li H; Smith L; Koyanagi A; Jacob L; Kronbichler A; Shin JI
Int J Biol Sci; 2020; 16(15):2906-2923. PubMed ID: 33061805
[TBL] [Abstract][Full Text] [Related]
27. Molecular characterization, pathogen-host interaction pathway and in silico approaches for vaccine design against COVID-19.
Singh N; Rai SN; Singh V; Singh MP
J Chem Neuroanat; 2020 Dec; 110():101874. PubMed ID: 33091590
[TBL] [Abstract][Full Text] [Related]
28. Molecular evolution and phylogenetic analysis of SARS-CoV-2 and hosts ACE2 protein suggest Malayan pangolin as intermediary host.
Lopes LR; de Mattos Cardillo G; Paiva PB
Braz J Microbiol; 2020 Dec; 51(4):1593-1599. PubMed ID: 32592038
[TBL] [Abstract][Full Text] [Related]
29. Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2.
Busnadiego I; Fernbach S; Pohl MO; Karakus U; Huber M; Trkola A; Stertz S; Hale BG
mBio; 2020 Sep; 11(5):. PubMed ID: 32913009
[TBL] [Abstract][Full Text] [Related]
30. Angiotensin-converting enzyme 2 (ACE2), SARS-CoV-2 and the pathophysiology of coronavirus disease 2019 (COVID-19).
Bourgonje AR; Abdulle AE; Timens W; Hillebrands JL; Navis GJ; Gordijn SJ; Bolling MC; Dijkstra G; Voors AA; Osterhaus AD; van der Voort PH; Mulder DJ; van Goor H
J Pathol; 2020 Jul; 251(3):228-248. PubMed ID: 32418199
[TBL] [Abstract][Full Text] [Related]
31. SARS-CoV-2: Immune Response Elicited by Infection and Development of Vaccines and Treatments.
Canedo-Marroquín G; Saavedra F; Andrade CA; Berrios RV; Rodríguez-Guilarte L; Opazo MC; Riedel CA; Kalergis AM
Front Immunol; 2020; 11():569760. PubMed ID: 33362758
[TBL] [Abstract][Full Text] [Related]
32. SARS-CoV-2/COVID-19 and advances in developing potential therapeutics and vaccines to counter this emerging pandemic.
Rabaan AA; Al-Ahmed SH; Sah R; Tiwari R; Yatoo MI; Patel SK; Pathak M; Malik YS; Dhama K; Singh KP; Bonilla-Aldana DK; Haque S; Martinez-Pulgarin DF; Rodriguez-Morales AJ; Leblebicioglu H
Ann Clin Microbiol Antimicrob; 2020 Sep; 19(1):40. PubMed ID: 32878641
[TBL] [Abstract][Full Text] [Related]
33. The SARS-Coronavirus Infection Cycle: A Survey of Viral Membrane Proteins, Their Functional Interactions and Pathogenesis.
Wong NA; Saier MH
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33525632
[TBL] [Abstract][Full Text] [Related]
34. Why COVID-19 Transmission Is More Efficient and Aggressive Than Viral Transmission in Previous Coronavirus Epidemics?
Elrashdy F; Redwan EM; Uversky VN
Biomolecules; 2020 Sep; 10(9):. PubMed ID: 32933047
[TBL] [Abstract][Full Text] [Related]
35. Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor.
Ge XY; Li JL; Yang XL; Chmura AA; Zhu G; Epstein JH; Mazet JK; Hu B; Zhang W; Peng C; Zhang YJ; Luo CM; Tan B; Wang N; Zhu Y; Crameri G; Zhang SY; Wang LF; Daszak P; Shi ZL
Nature; 2013 Nov; 503(7477):535-8. PubMed ID: 24172901
[TBL] [Abstract][Full Text] [Related]
36. [Diagnosis, treatment, control and prevention of SARS-CoV-2 and coronavirus disease 2019: back to the future].
Ye ZW; Jin DY
Sheng Wu Gong Cheng Xue Bao; 2020 Apr; 36(4):571-592. PubMed ID: 32347053
[TBL] [Abstract][Full Text] [Related]
37. The Immune Responses against Coronavirus Infections: Friend or Foe?
Vafaeinezhad A; Atashzar MR; Baharlou R
Int Arch Allergy Immunol; 2021; 182(9):863-876. PubMed ID: 33951640
[TBL] [Abstract][Full Text] [Related]
38. Coronavirus Infection-Associated Cell Death Signaling and Potential Therapeutic Targets.
Yapasert R; Khaw-On P; Banjerdpongchai R
Molecules; 2021 Dec; 26(24):. PubMed ID: 34946543
[TBL] [Abstract][Full Text] [Related]
39. Inactivating Three Interferon Antagonists Attenuates Pathogenesis of an Enteric Coronavirus.
Deng X; Buckley AC; Pillatzki A; Lager KM; Faaberg KS; Baker SC
J Virol; 2020 Aug; 94(17):. PubMed ID: 32554697
[TBL] [Abstract][Full Text] [Related]
40. N7-Methylation of the Coronavirus RNA Cap Is Required for Maximal Virulence by Preventing Innate Immune Recognition.
Pan R; Kindler E; Cao L; Zhou Y; Zhang Z; Liu Q; Ebert N; Züst R; Sun Y; Gorbalenya AE; Perlman S; Thiel V; Chen Y; Guo D
mBio; 2022 Feb; 13(1):e0366221. PubMed ID: 35073761
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
